We cocultured human primary CD34+ cells isolated from AML patients at diagnosis or CB-derived CD34+ AML cells with EVAML to test the metabolic modulation mediated by EVs exclusively on the hematopoietic cell compartment. The gene discussed is CD34; the disease is acute myeloid leukemia.